Loading organizations...
Loading organizations...
Targeted anti-cancer treatments based on synthetic lethality.
IMPACT Therapeutics has raised $95.2M across 3 funding rounds.
IMPACT Therapeutics has raised $95.2M in total across 3 funding rounds.
IMPACT Therapeutics has raised $95.2M in total across 3 funding rounds.
IMPACT Therapeutics's investors include Decheng Capital, Lilly Asia Ventures, China Summit Capital, Sungent BioVenture.
IMPACT Therapeutics has raised $95.2M across 3 funding rounds. Most recently, it raised $55.2M Series D in April 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 22, 2024 | $55.2M Series D | ||
| Aug 3, 2018 | $30.0M Series C | Decheng Capital | Lilly Asia Ventures |
| Feb 22, 2016 | $10.0M Series B | China Summit Capital, Lilly Asia Ventures, Sungent BioVenture |